![]() |
|
Comparison of extrafine and non-extrafine inhaled corticosteroids/long-acting β2-agonists as maintenance and reliever therapy in asthma: a randomized open-label crossover trial
Sang Pyo Lee, Sang Min Lee, Sung-Yoon Kang
Korean J Intern Med. 2025;40(3):491-501. Published online 2025 Apr 30 DOI: https://doi.org/10.3904/kjim.2024.393
|
|
Citations to this article as recorded by
Effect of Terbutaline Combined With Xiao’er Kechuanling on Efficacy and Airway Remodeling Indices in Children With Asthma
Xin Liu, Yanrong Liao
Clinical Pediatrics.2026; 65(3): 331. CrossRef Relative particle size and distribution of inhaled triple therapies
Brian Lipworth, Enrico Zambelli, Ruben Agazzi, Alessio Piraino
Annals of Allergy, Asthma & Immunology.2026; 136(5): 545. CrossRef Time to Rethink ICS Dosing in Pursuit of Asthma Clinical Remission: High-Dose ICS/LABA May Restore Short-Term Asthma Control When Medium Doses Fail
Marta Kołacińska-Flont, Izabela Kupryś-Lipińska, Maciej Wojakiewicz, Tomasz Dębowski, Piotr Kuna
Journal of Clinical Medicine.2026; 15(14): 5462. CrossRef
|